Financial reports
Current reports
8-K
Entry into a Material Definitive Agreement
4 Oct 21
8-K
Submission of Matters to a Vote of Security Holders
29 Sep 21
8-K
Entry into a Material Definitive Agreement
24 Sep 21
8-K
Transforming Community - Based Healthcare Corporate Presentation September 2021
7 Sep 21
8-K
Entry into a Material Definitive Agreement
30 Aug 21
8-K
LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics
20 Aug 21
8-K
Regulation FD Disclosure
16 Jul 21
8-K
LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare Acquisition Corp
7 Apr 21
8-K
Other Events
5 Mar 21
8-K
Report of Independent Registered Public Accounting Firm
4 Feb 21
Registration and prospectus
15-12B
Securities registration termination
12 Oct 21
25-NSE
Exchange delisting
29 Sep 21
25-NSE
Exchange delisting
29 Sep 21
25-NSE
Exchange delisting
29 Sep 21
425
Business combination disclosure
24 Sep 21
425
Business combination disclosure
7 Sep 21
425
Business combination disclosure
30 Aug 21
425
Business combination disclosure
20 Aug 21
425
Business combination disclosure
20 Aug 21
425
Business combination disclosure
19 Jul 21
Ownership
SC 13G/A
INTEGRATED CORE STRATEGIES (US) LLC
14 Feb 22
SC 13G
Senvest Management, LLC
24 Sep 21
SC 13G
INTEGRATED CORE STRATEGIES (US) LLC
14 Apr 21
3
Initial statement of insider ownership
26 Jan 21
3
Larry J Neiterman
26 Jan 21
3
Afsaneh Naimollah
26 Jan 21
3
Timothy J McMahon
26 Jan 21
3
DAVID S B LANG
26 Jan 21
3
David H Klein
26 Jan 21
3
Thomas M Cibotti
26 Jan 21